73
Participants
Start Date
June 24, 2009
Primary Completion Date
November 7, 2016
Study Completion Date
November 7, 2016
Everolimus
Everolimus 5 mg tablets were supplied in blister packs
Novartis Investigative Site, Berlin
Novartis Investigative Site, Milan
Novartis Investigative Site, Bologna
Novartis Investigative Site, Mainz
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Viagrande
Novartis Investigative Site, Bad Berka
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Lyon
Novartis Investigative Site, Marseille
Novartis Investigative Site, Paris
Novartis Investigative Site, Bad Berka
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bonn
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Mainz
Novartis Investigative Site, Munich
Novartis Investigative Site, Bologna
Novartis Investigative Site, Milan
Novartis Investigative Site, Perugia
Novartis Investigative Site, Roma
Novartis Investigative Site, Viagrande
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Madrid
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Glasgow
Novartis Investigative Site, Manchester
Novartis Investigative Site, Perugia
Novartis Investigative Site, Roma
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Glasgow - Scotland
Novartis Investigative Site, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY